FHC
CSTL icon

First Horizon Corporation’s Castle Biosciences CSTL Stock Holding History

First Horizon Corporation’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8K Buy
662
+75
+13% +$1.67K ﹤0.01% 1015
2026
Q1 		$14.4K Sell
587
-91
-13% -$2.98K ﹤0.01% 975
2025
Q4 		$26.4K Buy
678
+231
+52% +$7.45K ﹤0.01% 875
2025
Q3 		$10.2K Buy
+447
New +$9.08K ﹤0.01% 1066

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.98B AUM 29.21% 1-Year Est. Return

First Horizon Corporation's CSTL Position: Q2 2026 in Review

First Horizon Corporation increased its Castle Biosciences (CSTL) stake by 13% in Q2 2026, buying an estimated $1.67K and bringing the position to 662 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1015.

First Horizon Corporation first reported a position in CSTL in Q3 2025 and has held it in 4 quarters since. The position peaked at $26.4K in Q4 2025. 34 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • First Horizon Corporation held 662 shares of Castle Biosciences worth $15.8K as of Q2 2026.
  • First Horizon Corporation bought 75 Castle Biosciences shares in Q2 2026, an estimated $1.67K.
  • Castle Biosciences made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1015 holding.
  • First Horizon Corporation first reported a position in Castle Biosciences in Q3 2025 and has held it in 4 quarters since.
  • First Horizon Corporation's Castle Biosciences position peaked at $26.4K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.